RobertMichaelSwiftMDPh.D. Pharm/Physiol

Psychiatry • Providence, RI

Addiction

Professor, Psychiatry and Human Behavior, Brown University Program in Medicine

Join to view full profile

Dr. Swift is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Swift's full profile

Already have an account?

Office
830 Chalkstone Ave
Providence, RI 02908
Phone+1 401-457-3066

Education & Training

Yale-New Haven Medical CenterResidency, Psychiatry, 1979 - 1983
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1979

Certifications & Licensure

RI State Medical License 1983 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSD Start of enrollment: 2010 Jan 06
Completed
Phase 3
Aripiprazole and Topiramate on Free-Choice Alcohol Use Start of enrollment: 2007 Sep 01
Completed
Phase 2, Phase 3
Matching Genotypes and Serotonergic Medications for Alcoholism Start of enrollment: 2008 Sep 01
Completed
Phase 1
Doxazosin an a1 Antagonist for Alcohol Dependence Start of enrollment: 2011 Nov 01
Completed
Phase 2
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease Start of enrollment: 2012 Apr 01
Completed
Phase 2
Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms Start of enrollment: 2012 Jul 01
Completed
Phase 1, Phase 2
Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent Start of enrollment: 2014 Nov 01
Completed
Phase 1, Phase 2
Mifepristone for the Prevention of Relapses of Alcohol Drinking Start of enrollment: 2014 Sep 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations...
Erica Eaton, Christy Capone, Brian J Gully, Zoe E Brown, Mollie Monnig
Contemporary Clinical Trials Communications. 2024-10-01
Commentary on Efficacy and Safety of Low dose ondansetron as a prospective precision medicine to treat alcohol use disorder phenotypes.
Robert M Swift
European Journal of Internal Medicine. 2024-09-01
1 citations
Altered sleep architecture following consecutive nights of presleep alcohol.
Katie S McCullar, David H Barker, John E McGeary, Jared M Saletin, Caroline Gredvig-Ardito
Sleep. 2024-04-12

Press Mentions

What Is Viibryd Used ForJuly 25th, 2017
Here’s the One Thing You’ll Need to Stave off a New Years Eve HangoverDecember 31st, 2016
Improvement of Physical Health and Quality of Life of Alcohol-Dependent Individuals with Topiramate TreatmentUS Multisite Randomized Controlled TrialOctober 20th, 2016
Join now to see all

Grant Support

Aripiprazole And Topiramate On Free-Choice Alcohol UseNational Institute On Alcohol Abuse And Alcoholism2007–2011
Alcohol Phenotype Development In American SamoaNational Institute On Alcohol Abuse And Alcoholism2007–2008
Device For Acamprosate Transcutaneous Delivery To Reduce Alcohol Consumption.National Institute On Alcohol Abuse And Alcoholism2006
Medication/Psychotherapy Tailored To Patient ResourcesNational Institute On Alcohol Abuse And Alcoholism1999–2004
Assessment Of Alcohol Consumption By Transdermal EthanolNational Institute On Alcohol Abuse And Alcoholism1994–1996
Alcohol And The Human Leukocyte Beta-ReceptorNational Institute On Alcohol Abuse And Alcoholism1987–1989